Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE009 (AUS) (Dr. Novak)
· consented 2023-09-08
Adverse events
5
Serious AEs
1
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2024-01-22 (study day 130); relationship: N
mild
assessed
2026-08-18
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2024-06-19 (study day 279); relationship: not assessed
severe
serious
assessed
2026-08-18
Grade 4 Fatigue — outcome: RECOVERED/RESOLVED; onset 2024-07-09 (study day 299); relationship: not assessed; serious criteria: life-threatening
mild
assessed
2026-08-18
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2024-11-08 (study day 421); relationship: Y
moderate
assessed
2026-08-18
Grade 2 Decreased appetite — outcome: UNKNOWN; onset 2024-12-14 (study day 457); relationship: not assessed
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.